Edesa Biotech, Inc., 2026-06-26
An SEC Form D private-offering notice from Markham, ON, Canada, a $3,500,000 filer-stated offering target in Biotech. Filed 2026-06-26. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biopharmaceutical company developing treatments for inflammatory and immune-related diseases, including respiratory and dermatological conditions.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- SonoThera, Inc., 2026-06-30, $125.5M, South San Francisco, CA
- FibroBiologics, Inc., 2026-06-29, $3M, Houston, TX
- Rapalogix Health, Inc., 2026-06-26, $25M, Carlsbad, CA
- Arcadia Biosciences, Inc., 2026-06-26, $11.4M, Dallas, TX
- Chickadee Biomedicines, Inc., 2026-06-25, $1M, Boston, MA
- Exactics, Inc., 2026-06-25, $1.5M, Chicago, IL
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.